期刊文献+

早期子宫内膜癌盆腔淋巴结切除的意义探讨 被引量:8

Clinical significance of pelvic lymphadenectomy in early-stage endometrial cancer
原文传递
导出
摘要 目的探讨早期子宫内膜癌患者盆腔淋巴结转移率、相关因素及预后。方法对2006年1月至2011年3月北京协和医院初治、经全面手术病理分期、病变局限于子宫体的263例早期子宫内膜癌患者的临床资料进行回顾性分析。结果 263例患者中,21例发生盆腔淋巴结转移,转移率为7.98%。单因素分析显示,肿瘤中低分化、肌层浸润深度≥1/2、非子宫内膜样癌、血管淋巴间隙受累(LVSI)、血清CA125≥35U/L是早期子宫内膜癌盆腔淋巴结转移的危险因素。多因素分析显示,仅深肌层浸润和肿瘤中、低分化是早期子宫内膜癌盆腔淋巴结转移的独立危险因素。淋巴结转移组和非转移组的3年无瘤生存率分别为66.7%(14/21)及99.2%(240/242),两组比较,差异有统计学意义(P=0.000)。结论早期子宫内膜癌合并盆腔淋巴结转移的概率低,深肌层浸润及肿瘤中、低分化是盆腔淋巴结转移的独立影响因素。 Objective To study the incidence of pelvic lymph node metastasis,risk factors and prognosis in early-stage endometrial carcinoma.Methods 263 patients with early-stage endometrial carcinoma who underwent hysterectomy plus bilateral salpingo-oophorectomy plus pelvic and/or para-aortic lymphadenectomy between January2006 and March 2011 in Peking Union Medical College Hospital recruited in this study,data was analyzed retrospectively.Results The incidence of pelvic lymph node(PLN)metastasis was 7.98%.The positive PLN rate was higher in patients with grade 2/3,deep myometrial invasion,non-endometrioid endometrial carcinoma,lymphovascular space involvement(LVSI)and CA125≥35 U/L.The multivariate analysis revealed that deep myometrial invasion and grade 2/3were independent risk factors for lymph node metastasis.The 3-year disease-free survival rate of patients with PLN metastasis and no PLN metastasis were 66.7% and 99.2%,respectively(P=0.000).Conclusions The incidence of PLN metastasis in early-stage endometrial carcinoma is low.Deep myometrial invasion and grade 2/3were independent risk factors for PLN metastasis.
出处 《中国妇产科临床杂志》 CSCD 北大核心 2015年第2期130-132,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 国家科技支撑计划,妇科疾病现代治疗规范化研究(2008BAI57B00)
关键词 子宫内膜癌 盆腔淋巴结转移 深肌层浸润 预后 endometrial neoplasms pelvic lymph node metastasis deep myometrial invasion prognosis
  • 相关文献

参考文献11

  • 1Creasman WT,IVbrrow CP, Bundy et al Surgical patho-logic spread patterns of endometrial cancer. A Gynecologic Chcolo-gy Group Study. Cancer, 1987, 60: 2035 - 2041.
  • 2Zhang CY, Wang C, Feng WW. Clinicopathological risk fac-tors for pelvic lymph node metastasis in clinical early - stageendometrioid endometrial adenocarcinoma. Int J GynecolCancer,2012,22: 1373- 1377.
  • 3Amant F, Moerman P, Neven P,et al. Endometrial cancer.Lancet,2005,366: 491 - 505.
  • 4田兆华,王建六.应客观评价腹膜后淋巴结切除在子宫内膜癌的治疗价值[J].中国计划生育和妇产科,2011,3(3):5-7. 被引量:2
  • 5王志启,张燕,王建六,沈丹华,赵昕,姚远洋,白云,魏丽惠.子宫内膜癌淋巴结转移的特征及对预后的影响[J].中华妇产科杂志,2011,46(6):435-440. 被引量:29
  • 6Karube Y, Fujimoto T,Takahashi O, et al. Histopatho-logical prognostic factors predicting para - aortic lymph nodemetastasis in patients with endometrioid uterine cancer , Gy-necol Oncol. 2010, 118: 151 - 154.
  • 7Fujimoto T, Fukuda J, Tanaka T. Role of complete para -aortic lymphadenectomy in endometrial cancer. Curr OpinObstet Gynecol, 2009,21: 10 - 14.
  • 8Akbayir 0,Corbacioglu A,Goksedef BP, et al. The novelcriteria for predicting pelvic lymph node metastasis in endom-etrioid adenocarcinoma of endometrium. Gynecol Oncol,2012,125: 400-403.
  • 9Benedetti Panici P,Basile S,Maneschi F,et al. Systematicpelvic lymphadenectomy vs. no lymphadenectomy in early -stage endometrial carcinoma : randomized clinical trial. J NatlCancer Inst,2008,100: 1707 - 1716.
  • 10叶磊,朱建龙,冯令达,翁雷,陆惠娟.盆腹腔淋巴取样术在子宫内膜癌手术中的临床意义[J].中国妇产科临床杂志,2012,13(3):194-197. 被引量:7

二级参考文献30

  • 1吴玉梅,徐小红,张铁娟,邓小虹.分期手术治疗子宫内膜癌临床价值的探讨[J].北京医学,2005,27(1):25-29. 被引量:7
  • 2吴婉莉,万小云,谢幸.Ⅰ期子宫内膜癌盆腔淋巴清扫术的意义[J].现代妇产科进展,2006,15(10):746-749. 被引量:18
  • 3Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium [ J ]. Int J Gynecol Obstet, 2009, 105(2) : 103 -104.
  • 4Benedetti P, Basile S , Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early -stage endometrial carcinoma: randomized clinical trial[ J]. J Natl Cancer Inst, 2008, 100(23): 1707-1716.
  • 5Nonmra H, Aoki D, Suzuki N, et al. Analysis of clinicopathologic factors predicting para - aortic lymph node metastasis in endometrial cancer[J]. Int J Gynecol Cancer, 2006, 16(2) : 799 -804.
  • 6Yaegashi N, Ito K, Niikura H. Lymphadenectomy for endometrial carcer: is paraaortic lymphadenectomy necessary [ J ] ? Int J Clin Oncol, 2007, 12:176-180.
  • 7Todo Y, Kato H, Kaneuchi M, et al. Survival effect of para - aortic lymphadenectomy in endometrial cancer (SEPAL study) : a retrospective cohort analysis [ J ]. Lancet, 2010, 375 ( 9721 ) : 1165 -1172.
  • 8Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin ,2010,60:277-300.
  • 9Mariani A, Webb M J, Keeney GL, et al. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol,2001,81 : 100-104.
  • 10Karasek K, Faul C. Changing concepts in the management of endometrial cancer. Oncology ( Williston Park), 1996,10: 1099- 1106.

共引文献35

同被引文献73

  • 1胡春霞,金松,凌奕,何超蔓,吴玲,蒋华,纪武,曹俊伟.子宫内膜癌盆腔淋巴结的临床病理特征分析[J].中国热带医学,2007,7(6):923-925. 被引量:3
  • 2Siegel R,Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013,63(1) :11-30.
  • 3Brown AP,Gaffney DK, Dodson MK, et al. Survival analysis of endometrial cancer patients with positive lymph nodes[J]. Int J Gyneeol Cancer,2013,23(5) :861-868.
  • 4Kuku S,Williams MM. Adjuvant therapy in stage Ⅲ endometri- al cancer: treatment outcomes and survival: a single-institution retrospective study[J]. Int J Gyneeol Cancer, 2013,23 (6) : 1056- 1064.
  • 5Chi DS,Barakat RR,Palayekar MJ,et al. The incidence of pelvic lymphnode metastasis by FIGO staging for patients with ade- quately surgically staged endometrial adenocarcinoma of endometrioid histology[J]. Int J Gynecol Cancer, 2008, 18 (2) : 269- 273.
  • 6Todo Y,Kato H,Kaneuchi M, et al. Survival effect of paraarotic lymphadenectomy in endometrial cancer(SEPAL study) :a retro- spective cohort analysis [J]. Lancet, 2010, 375 ( 9721 ) : 1165- 1172.
  • 7Kitchener H,Swart AM, Qian Q, et al. Efficacy of systematic pelvic lymphadeneetomy in endometrial cancer (MRC ASTEC trial) ; a randomised study [J]. Lancet, 2009,373 ( 9658 ) : 125- 136.
  • 8Benedetti Panici P,Basile S,Maneschi F,et al. Systematic pelvic- lymphadenectomy vs. no lymphadenectumy in early-stage endom- etrial carcinoma:randomized clinical trial[J]. J Natl Cancer Inst, 2008,100(23) : 1707-1716.
  • 9Tong SY,Lee JM,Chui YJ,et al. Efficacy of systematic pelvic lymph- adenectomy in patients with non-endumetrioid endometrial cancers: a retrospective,multicenter study in Korea [J]. Obstet Gynaecol Res, 2012,38(11) :1321-1327.
  • 10Guntupalli SR, Zighelboim I, Kizer NT, et al. Lymphovaseular space invasion is an independent risk factor for nodal disease and poor out- comes in endometrioid endometrial cancer[J]. Gynecul Oncol, 2012, 124(1) :31-35.

引证文献8

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部